{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:13:36Z","timestamp":1788268416368,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jacig.2026.100652","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:54:57Z","timestamp":1770944097000},"page":"100652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Peanut oral immunotherapy at a single academic medical center using a volume-based approach with store-purchased peanut products"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6341-5794","authenticated-orcid":false,"given":"Ashley L.","family":"Devonshire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Z.","family":"Magier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget E.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Winslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Risma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Pablo","family":"Abonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Sherenian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal H.","family":"Assa\u2019ad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Andorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin T.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2026.100652_bib1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-2102","article-title":"Peanut allergy: new advances and ongoing controversies","volume":"145","author":"Abrams","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacig.2026.100652_bib2","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/cea.13287","article-title":"Food-induced fatal anaphylaxis: from epidemiological data to general prevention strategies","volume":"48","author":"Pouessel","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2026.100652_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100512","article-title":"The Peanut Allergy Burden Study: impact on the quality of life of patients and caregivers","volume":"14","author":"Nowak-Wegrzyn","year":"2021","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jacig.2026.100652_bib4","series-title":"Center for Biologics Evaluation and Research - Palforzia approval letter","year":"2020"},{"key":"10.1016\/j.jacig.2026.100652_bib5","unstructured":"Reindel R. July 26, 2024 Approval Letter - PALFORZIA - U.S. Food and Drug Administration (STN: BL 125696\/247 Supplement Approval). Division of Clinical and Toxicology Review, Office of Research and Review, Center for Biologics Evaluation and Research, U.S. Food & Drug Administration: 2024. https:\/\/www.fda.gov\/media\/180366\/download."},{"key":"10.1016\/j.jacig.2026.100652_bib6","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2026.100652_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41598-019-56961-3","article-title":"Adverse events associated with peanut oral immunotherapy in children - a systematic review and meta-analysis","volume":"10","author":"Grzeskowiak","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacig.2026.100652_bib8","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jaci.2021.12.780","article-title":"Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: pooled summary of phase 3 and extension trials","volume":"149","author":"Brown","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2026.100652_bib9","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.jaip.2019.04.007","article-title":"The real world is not standardized","volume":"7","author":"Wasserman","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100652_bib10","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.jaip.2019.04.008","article-title":"Reply","volume":"7","author":"Wang","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100652_bib11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jaip.2024.02.032","article-title":"Implementing food oral immunotherapy into clinical practice: quality and safety perspectives from a US academic center","volume":"12","author":"Winslow","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100652_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaip.2019.09.004","article-title":"The role of shared decision making in pediatric food allergy management","volume":"8","author":"Anagnostou","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100652_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100455","article-title":"Oral immunotherapy for peanut allergy: the pro argument","volume":"13","author":"Chinthrajah","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jacig.2026.100652_bib14","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet"},{"issue":"10322","key":"10.1016\/j.jacig.2026.100652_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2026.100652_bib16","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.jaip.2020.03.016","article-title":"Community private practice clinical experience with peanut oral immunotherapy","volume":"8","author":"Afinogenova","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100652_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.anai.2019.08.463","article-title":"Oral immunotherapy for multiple foods in a pediatric allergy clinic setting","volume":"123","author":"Eapen","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2026.100652_bib18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.anai.2021.04.003","article-title":"Peanut oral immunotherapy in a pediatric allergy clinic: patient factors associated with clinical outcomes","volume":"127","author":"Guarnieri","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2026.100652_bib19","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jaip.2019.04.010","article-title":"First real-world safety analysis of preschool peanut oral immunotherapy","volume":"7","author":"Soller","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100652_bib20","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jaip.2020.10.045","article-title":"First real-world effectiveness analysis of preschool peanut oral immunotherapy","volume":"9","author":"Soller","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100652_bib21","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaip.2018.05.023","article-title":"Real-World experience with peanut oral immunotherapy: lessons learned from 270 patients","volume":"7","author":"Wasserman","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100652_bib22","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400306","article-title":"Peanut oral immunotherapy in children with high-threshold peanut allergy","volume":"4","author":"Sicherer","year":"2025","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jacig.2026.100652_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2026.100652_bib24","unstructured":"What\u2019s in the foods you eat search tool, [Internet] 2019-2020 [cited 8\/17\/23]. The current version, 2021-2023 is available from: https:\/\/www.ars.usda.gov\/northeast-area\/beltsville-md-bhnrc\/beltsville-human-nutrition-research-center\/food-surveys-research-group\/docs\/whats-in-the-foods-you-eat-search-tool\/."},{"key":"10.1016\/j.jacig.2026.100652_bib25","series-title":"Nutrition data system for research","year":"1992"},{"key":"10.1016\/j.jacig.2026.100652_bib26","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 Oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2026.100652_bib27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jaip.2022.10.022","article-title":"Retail Food Equivalents for Post-Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical Trial","volume":"11","author":"Groetch","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100652_bib28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2026.100652_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.annemergmed.2006.01.018","article-title":"Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"47","author":"Sampson","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacig.2026.100652_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1939-4551-7-9","article-title":"International consensus on (ICON) anaphylaxis","volume":"7","author":"Simons","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jacig.2026.100652_bib31","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jaci.2025.05.026","article-title":"Comparison of an FDA-approved peanut oral immunotherapy product with peanut food products","volume":"156","author":"Casale","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2026.100652_bib32","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2352-4642(20)30234-0","article-title":"Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial","volume":"4","author":"O\u2019B Hourihane","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jacig.2026.100652_bib33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/pai.12914","article-title":"Long-term outcome of peanut oral immunotherapy-real-life experience","volume":"29","author":"Nachshon","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jacig.2026.100652_bib34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/ACI.0000000000000537","article-title":"Eosinophilic esophagitis during sublingual and oral allergen immunotherapy","volume":"19","author":"Cafone","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2026.100652_bib35","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1016\/j.jaip.2021.07.017","article-title":"Management of eosinophilic esophagitis during oral immunotherapy","volume":"9","author":"Chu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100652_bib36","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jaip.2022.11.010","article-title":"Treatment of oral immunotherapy-associated eosinophilic esophagitis","volume":"11","author":"Epstein-Rigbi","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2026.100652_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MPG.0000000000003631","article-title":"Oral immunotherapy and risk of eosinophilic esophagitis in children: 15 years' experience","volume":"76","author":"Morales-Cabeza","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829326000147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829326000147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:16:03Z","timestamp":1788264963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829326000147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2772829326000147"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2026.100652","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peanut oral immunotherapy at a single academic medical center using a volume-based approach with store-purchased peanut products","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2026.100652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100652"}}